Donor Allospecific CD44 Central Memory T Cells Have Decreased Ability to Mediate Graft-vs.-Host Disease
Overview
Affiliations
Data from both animal models and humans have demonstrated that effector memory T cells (T) and central memory T cells (T) from unprimed donors have decreased ability to induce graft-vs-host disease (GVHD). Allospecific T from primed donors do not mediate GVHD. However, the potential of alloreactive T to induce GVHD is not clear. In this study, we sought to answer this question using a novel GVHD model induced by T cell receptor (TCR) transgenic OT-II T cells. Separated from OT-II mice immunized with OVA protein 8 weeks earlier, the allospecific CD44 T were able to mediate skin graft rejection after transfer to naive mice, yet had dramatically decreased ability to induce GVHD. We also found that these allospecific CD44 T persisted in GVHD target organs for more than 30 days post-transplantation, while the expansion of these cells was dramatically decreased during GVHD, suggesting an anergic or exhausted state. These observations provide insights into how allospecific CD4 T respond to alloantigen during GVHD and underscore the fundamental difference of alloresponses mediated by allospecific T in graft rejection and GVHD settings.
Li P, Huang M, Li M, Li G, Ma Y, Zhao Y J Exp Clin Cancer Res. 2025; 44(1):72.
PMID: 40001264 PMC: 11863571. DOI: 10.1186/s13046-025-03332-8.
Popova N, Drokov M, Davydova Y, Kapranov N, Vasilieva V, Galtseva I Int J Hematol Oncol Stem Cell Res. 2024; 18(1):33-46.
PMID: 38680716 PMC: 11055426. DOI: 10.18502/ijhoscr.v18i1.14742.
TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responses.
Harris R, Mammadli M, Hiner S, Suo L, Yang Q, Sen J Cancer Immunol Immunother. 2022; 72(6):1581-1601.
PMID: 36562825 PMC: 10198945. DOI: 10.1007/s00262-022-03323-0.
Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?.
Dekker L, Sanders E, Lindemans C, de Koning C, Nierkens S Front Immunol. 2022; 13:893545.
PMID: 35795679 PMC: 9250980. DOI: 10.3389/fimmu.2022.893545.
Song Q, Nasri U, Nakamura R, Martin P, Zeng D Front Immunol. 2022; 13:907673.
PMID: 35677056 PMC: 9168269. DOI: 10.3389/fimmu.2022.907673.